三参通络合剂治疗气虚血瘀型缺血性中风的临床疗效  

Clincial observation on treating Qixu Xueyu type of ischemic stroke with Sanshen Tongluo mixture

作　　者：骆彤[1] 李鹏[1] 阮明军 

机构地区：[1]济宁市中医院,山东济宁272100

出　　处：《中医临床研究》2015年第1期7-9,共3页Clinical Journal Of Chinese Medicine

基　　金：济宁市2013年度中医药科技项目(编号:zk201325)

摘　　要：目的:观察三参通络合剂治疗气虚血瘀型缺血性中风的临床疗效。方法:观察选取缺血性中风辨证为气虚血瘀型病例106例,采用数字法随机分为治疗组和对照组,对照组给予常规西药治疗,治疗组加服三参通络合剂;15d为1个疗程,共观察2个疗程。分析比较两组临床疗效、神经功能缺损情况、中医证候积分情况。结果:治疗组总有效率为92.4%,对照组仅为81.1%,两组比较有显著性差异(P<0.05);治疗后神经功能缺损评分及中医气虚血瘀证积分对比,治疗组较对照组改善更明显,两组比较有显著性差异(P<0.05)。结论:三参通络合剂治疗气虚血瘀型缺血性中风急性期患者可获得较为满意的疗效。Objective： To observe clinical effects of Sanshen Tongluo mixture on Qixu Xueyu type of ischemic stroke. Methods： 106 patients were divided into the treatment group and the control group, the control group was given routine western medicine treatment, while the treatment group was given Sanshen Tongluo mixture, 15 days for 1 course, with 2 courses of treatment, clinical effects, situation of neurological deficit, and the symptom score were compared between two groups. Results： The total efficiency in the treatment group （92.4%） was significantly better than that （81.1%） in the control group （P〈0.05）. Neurological deficits and TCM ASDP scores in the treatment group were significantly better than those in the control group （P〈0.05）. Conclusion： Clinical effects of Sanshen Tongluo mixture on Qixu Xueyu type of ischemic stroke was satisfactory.

关 键 词：缺血性中风 气虚血瘀型 三参通络合剂 

分 类 号：R255.2[医药卫生—中医内科学]